Clinical trial · Interventional
Investigation of Desmoplastic Squamous Cell Carcinoma
Prospektive Therapie-Studie Zur Behandlung Des Desmoplastischen Plattenepithelkarzinoms
NCT02717936CI-TRIAL-00021506DesmoPEKunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Aim of the study is to verify wether it is possible to have a more sensitive diagnostic tool using pancytokeratin immunohistochemistry for desmoplastic squamous cell carcinoma compared to regular H\&E staining. The investigators therefore plan to include 73 participants with a confirmed diagnosis of desmoplastic squamous cell carcinoma and do regular follow up.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Squamous Cell Carcinoma of the Skin | Skin Squamous Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Immunohistochemistry using Pancytokeratin Staining | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Immunohistochemistry
- description
- Patients are investigated using immunohistochemistry with Pancytokeratin
- interventionNames
- Procedure: Immunohistochemistry using Pancytokeratin Staining
Primary outcomes (1)
- measure
- Recurrence free survival of patients with desmoplastic squamous cell carcinoma (SCC) diagnosed with immunohistochemistry .
- timeFrame
- 4 years
Secondary outcomes (4)
- measure
- Reduction of local recurrence with immunohistochemistry
- timeFrame
- 4 years
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * desmoplastic squamous cell carcinoma (SCC) of the skin Exclusion Criteria: * tumor recurrence * collision tumors * other skin malignancies * progeria * Rothmund-Thomson-Syndrome * lacking of the capacity for informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.